منابع مشابه
[Disease management programs in heart failure: one step beyond pharmacology].
Despite pharmacological advances, both mortality and the incidence of hospital admissions are high for heart failure. As with many other chronic diseases, the findings of clinical trials are difficult to implement due to lack of adherence to treatment, frequent comorbidities not considered in clinical trials, and health systems’ typical focus on acute diseases. Public health systems usually pay...
متن کاملHeart failure disease management programs: not a class effect.
Heart failure (HF) remains a major public health problem that affects 5 million patients in the United States.1 HF is the leading cause of hospitalization for people 65 years of age and older, and rates of hospital readmission within 6 months range from 25% to 50%.1,2 The personal burden of HF includes debilitating symptoms, frequent rehospitalizations, and high rates of mortality.2 HF also pos...
متن کاملHeart failure disease management programs: a cost-effectiveness analysis.
BACKGROUND Heart failure (HF) disease management programs have shown impressive reductions in hospitalizations and mortality, but in studies limited to short time frames and high-risk patient populations. Current guidelines thus only recommend disease management targeted to high-risk patients with HF. METHODS This study applied a new technique to infer the degree to which clinical trials have...
متن کاملDisease Management for Heart Failure
s from more than 4800 biomedical journals [4] Di se as e M an ag em en t f or H ea r F ai lu re published in the United States and 70 other countries. Topics span the fields of medicine, nursing, dentistry, veterinary medicine, the health care system, and the preclinical sciences. Earlier versions of this bibliography were based on searches of the MEDLINE database for the period from January 19...
متن کامل[Heart failure management programs: in favour of universal implementation].
The creation of care programs for patients with heart failure is reflected in the most recent update of the guidelines for the treatment of chronic heart failure of the European Society of Cardiology, with a class I recommendation and level A evidence for the reduction of hospitalization and a class IIa recommendation and level B evidence for reduction of mortality.1 The sophistication and comp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2004
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.0000151101.17629.20